By:Ron Judd From: thenewstribune.com The microscopic particles that might change the world are being carted about on a medical campus near Seattle’s Lake Union. The mode of transport: a plastic lunch cooler. The little coolers are ubiquitous at the Fred Hutchinson Cancer Research Center, which four decades ago pioneered a groundbreaking treatment for blood cancers — the bone-marrow transplant, now an older …
Congress Passes Right-to-Try Bill
By: Kerry Dooley Young From: medscape.com WASHINGTON — House lawmakers passed a “right-to-try” bill today, clearing the path for President Donald J. Trump to sign it. The bill is intended to make it easier for people with life-threatening conditions to access experimental treatments outside of clinical trials. Many advocacy groups argue the measure will erode needed protections and put patients at …
BREAST CANCER AWARENESS EXHIBITION
OCTOBER 2018, POLLAK LIBRARY – CALIFORNIA STATE UNIVERSITY FULLERTON This exhibition features art work about breast cancer created by CSUF faculty, staff, and students, as well as members of the local community. Please join us in exploring the personal, political, social and medical issues related to breast cancer. According to the American Cancer Society, “Breast cancer is the most common cancer in …
New computational strategy designed for more personalized cancer treatment
Source :Johns Hopkins University From: sciencedaily.com Mathematicians and cancer scientists have found a way to simplify complex biomolecular data about tumors, in principle making it easier to prescribe the appropriate treatment for a specific patient. The new computational strategy transforms highly complex information into a simplified format that emphasizes patient-to-patient variation in the molecular signatures of cancer cells, the researchers say. …
Deadly brain cancer stopped with new compound
By; Ana Sandoiu From: medicalnewstoday.com Glioblastoma, one of the deadliest forms of brain cancer, may have found its nemesis. New research shows that the tumor, which is notoriously difficult to treat, can be halted by an experimental compound. Glioblastoma is a particularly aggressive form of brain tumor, with a median survival rate of 10–12 months. Part of the reason why glioblastomas are so deadly is that …
Why I Knew Nothing About Breast Cancer When I Was Diagnosed
View PostPET scan tracer predicts success of cancer ‘vaccine’
By: HANAE ARMITAGE From: stanford.edu With a radioactive tracer, scientists can use a PET scan to quickly tell whether a cancer immunotherapy will be effective or not, according to a new Stanford study. By engineering a special molecule to track certain immune cells in the body, scientists at the Stanford University School of Medicine have invented a litmus test for the effectiveness of a …
New Tool Helps People with Leukemia Better Understand Their Treatment Options
National Comprehensive Cancer Network releases NCCN Guidelines for Patients: AML The National Comprehensive Cancer Network®(NCCN®) has released a free booklet to empower people with acute myeloid leukemia (AML) and their loved ones with resources for better-informed medical decision-making. The NCCN Guidelines for Patients: AML publication was made possible thanks to funding from the NCCN Foundation®, and sponsorship from Be The Match®. It …
Multigene testing replacing BRCA tests for breast cancer risk
By: KRISTA CONGER From: stanford.edu Tests to detect mutations in multiple genes are replacing BRCA-only analyses in women with breast cancer, according to a study by scientists at Stanford and several other institutions. Greater access to genetic counselors needed. The use of genetic tests aimed at detecting the presence of mutations in the BRCA1 and BRCA2 genes in women with breast cancer …
Breast Cancer School for Patients Launches – a public service educational website for women
Gainesville, VA — (May 2018) – Introducing the Breast Cancer School for Patients, the very first one-stop online resource designed to bridge the breast cancer education gap between patient and doctor. The online school is built on the idea that patients will make better treatment decisions when they are taught to be an “expert” in their own breast cancer care. Creator Dr. …